[1]王桂霞,郭雨璐,刘子强,等.基于CiteSpace的酒精性肝病知识图谱可视化分析[J].医学信息,2024,37(05):27-32.[doi:10.3969/j.issn.1006-1959.2024.05.004]
 WANG Gui-xia,GUO Yu-lu,LIU Zi-qiang,et al.Visualization Analysis of Alcoholic Liver Disease Knowledge Map Based on CiteSpace[J].Journal of Medical Information,2024,37(05):27-32.[doi:10.3969/j.issn.1006-1959.2024.05.004]
点击复制

基于CiteSpace的酒精性肝病知识图谱可视化分析()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年05期
页码:
27-32
栏目:
医学数据科学
出版日期:
2024-03-01

文章信息/Info

Title:
Visualization Analysis of Alcoholic Liver Disease Knowledge Map Based on CiteSpace
文章编号:
1006-1959(2024)05-0027-06
作者:
王桂霞郭雨璐刘子强
(湘南学院基础医学院1,临床学院2,湖南 郴州 423000)
Author(s):
WANG Gui-xiaGUO Yu-luLIU Zi-qianget al.
(Basic Medical College1,Clinical College2,Xiangnan University,Chenzhou 423000,Hunan,China)
关键词:
酒精性肝病中西医联合治疗乙醇代谢CiteSpace
Keywords:
Alcoholic liver diseaseCombined treatment of traditional Chinese and western medicineEthanol metabolismCiteSpace
分类号:
R575
DOI:
10.3969/j.issn.1006-1959.2024.05.004
文献标志码:
A
摘要:
目的 对我国近10年来酒精性肝病相关文献进行计量、可视化分析,探究其研究热点和发展趋势。方法 检索中国知网(CNKI)检索收录的2012-2021年酒精性肝病研究相关文献,运用CiteSpace6.1.R2软件通过文献计量学方法对发文量、作者、机构、关键词等进行可视化分析。结果 研究共筛选纳入974篇文献,年度发文量平稳输出,形成以邹正升、李保森、郝书理、黄昂等作者为代表的较稳定的研究团队,团队内合作紧密,但团队间缺乏合作;发文机构分析显示,中国医科大学附属第一医院是发文量最多的机构,机构合作呈现的主要研究力量是中医学类高校及其附属医院,集中在北京,跨地区合作较少;关键词分析显示,酒精性肝病主要在发病机制、动物模型、中医治疗、中西医联合治疗等方面开展大量研究。结论 中医治疗、中西医联合治疗与发病机制研究为酒精性肝病热点趋势。
Abstract:
Objective To conduct a quantitative and visual analysis of the literature related to alcoholic liver disease in China in the past decade, and to explore its research hotspots and development trends.Methods The literatures related to alcoholic liver disease research from 2012 to 2021 were retrieved from China National Knowledge Infrastructure(CNKI). The CiteSpace6.1.R2 software was used to visually analyze the number of publications, authors, institutions, keywords, etc. through bibliometric methods.Results A total of 974 literatures were screened and included in the study. The annual output of the literatures was stable, forming a relatively stable research team represented by ZOU Zheng-sheng, LI Bao-sen, HAO Shu-li, HUANG Ang and other authors. The cooperation within the team was close, but there was a lack of cooperation between the teams. The analysis of publishing institutions showed that the First Affiliated Hospital of China Medical University was the institution with the largest number of publications. The main research force of institutional cooperation was TCM universities and their affiliated hospitals, which were concentrated in Beijing, but its had less cross-regional cooperation. Keyword analysis showed that alcoholic liver disease mainly carried out a lot of research in the pathogenesis, animal models, traditional Chinese medicine treatment, combined treatment of traditional Chinese and Western medicine.Conclusion Traditional Chinese medicine treatment, combined treatment of traditional Chinese and Western medicine and pathogenesis research are the hot trends of alcoholic liver disease.

参考文献/References:

[1]南然,李宜璇.清肝化湿活血汤联合水飞蓟宾胶囊对酒精性肝病患者肝纤维化指标的影响[J].实用医学杂志,2022,38(8):1022-1026.[2]张晓晶,武瑞,黄伟,等.还原型谷胱甘肽联合多烯磷脂酰胆碱治疗酒精性肝病临床疗效观察[J].中国卫生检验杂志,2022,32(21):2603-2605,2609.[3]曾思雨,高谨椤,彭晨宇,等.基于CiteSpace的尘肺病国内外研究热点分析[J].湘南学院学报(医学版),2022,24(3):36-42.[4]张昕洋,廖星,刘雪梅,等.中药复方治疗脑小血管病相关认知功能障碍随机对照试验的结局指标分析[J].中国中药杂志,2020,45(23):5804-5818.[5]伍翔群.没食子酸卵磷脂复合物的制备及对小鼠酒精性肝病铁过载保护作用研究[D].长春:吉林大学,2019.[6]相君妍.五味子提取物对酒精性肝病小鼠的干预作用及其机制研究[D].长春:吉林大学,2022.[7]张译文,李昱锦,胡冰芳,等.三种小鼠酒精性肝病短期模型的评价[J].药学学报,2018,53(2):236-243.[8]黄东东,沃璐璐,阮昕,等.新型酒精性肝病小鼠模型的建立[J].上海交通大学学报(医学版),2017,37(7):906-913.[9]苏俊.小鼠酒精性肝纤维化模型的建立及酒精性肝病的临床分析[D].广州:第一军医大学,2007.[10]于泓洋,刘孟奇,曲仕钊,等.美他多辛对酒精性肝病的保护作用[J].齐齐哈尔医学院学报,2022,43(23):2209-2212.[11]方永光.异甘草酸镁、硫普罗宁治疗酒精性肝病的疗效对比[J].吉林医学,2010,31(17):2624-2625.[12]林松挺,陈正义.左卡尼汀联合多烯磷脂酰胆碱对酒精性肝病的疗效[J].贵阳医学院学报,2015,40(8):882-885.[13]毕德飞,杨琼芬,蒋俊,等.左卡尼汀联合还原型谷胱甘肽治疗酒精性肝病的效果[J].云南医药,2015,36(4):466-467.[14]中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会.酒精性肝病防治指南(2018年更新版)[J].临床肝胆病杂志,2018,34(5):939-946.[15]相芳萍,卢秉久.卢秉久治疗酒精性肝病经验[J].山东中医杂志,2016,35(3):237-238.[16]陈亚男,卢秉久.卢秉久疏肝理脾辨治酒精性肝病经验[J].湖南中医杂志,2018,34(1):27-29.[17]于立红,卢秉久.卢秉久教授配伍运用楮实子与枳椇子治疗酒精性肝病经验[J].浙江中医药大学学报,2013,37(7):884-885.[18]于成文,卢秉久.中医药辨证治疗酒精性肝病浅析[J].实用中医内科杂志,2011,25(2):60.[19]马彦平.化浊祛瘀汤治疗酒精性肝病的实验研究[J].世界中西医结合杂志,2009,4(10):707-709.[20]王林元,屈胜胜,王景霞,等.巴西莓对大鼠慢性酒精性肝损伤的保护作用及对TGF-β1、CD68的影响[J].卫生研究,2014,43(6):1018-1021.[21]郎涵,魏嵋,汪静,等.葛黄颗粒对酒精性肝病模型大鼠的防治作用[J].重庆医学,2017,46(3):305-307.[22]沈菲.葛黄颗粒对酒精性肝病模型大鼠的防治作用及其机制研究[D].泸州:西南医科大学,2016.[23]梁杨.葛黄颗粒对酒精性肝病模型大鼠的药效学研究[D].泸州:西南医科大学,2017.[24]陈晓琳,王希利.王希利教授治疗酒精性肝病经验撷要[J].实用中医内科杂志,2008,(7):18-19.[25]舒发明,黄英,刘业方,等.从伏邪学说探讨酒精性肝病治疗思路[J].时珍国医国药,2015,26(7):1708-1710.[26]谢函君,叶志伟.中西医结合治疗酒精性肝病疗效观察[J].湖北中医药大学学报,2015,17(6):71-73.[27]洪玫,段宏宪,杨敏.清肝化湿活血汤联合复方甘草酸苷片治疗酒精性肝病的临床疗效及对患者肝功能的影响[J].医药论坛杂志,2023,44(2):87-89,93.

相似文献/References:

[1]罗 晨,杨嘉恩,梁惠卿.酒精性肝病中西医辨治研究进展[J].医学信息,2018,31(15):16.[doi:10.3969/j.issn.1006-1959.2018.15.008]
 LUO Chen,YANG JIA-en,LIANG HUI-qin.Advances in Differentiation and Treatment of Traditional Chinese and Western Medicine for Alcoholic Hepatitis[J].Journal of Medical Information,2018,31(05):16.[doi:10.3969/j.issn.1006-1959.2018.15.008]

更新日期/Last Update: 1900-01-01